Beyond AREDS2: The Next Evolution in Nutritional Support for Macular Degeneration
For more than two decades, the Age-Related Eye Disease Studies (AREDS and AREDS2), led by the National Eye Institute, have shaped how eye doctors approach nutritional support for age-related macular degeneration (AMD).
These landmark clinical trials demonstrated that targeted nutritional supplementation could reduce the risk of progression from intermediate AMD to advanced vision-threatening disease by approximately 25%.
For many patients, AREDS2 became the standard of care. But science continues to evolve—and so does our understanding of AMD.
Today, researchers increasingly recognize that AMD is not simply a disease of aging eyes or drusen deposits. At a deeper biological level, AMD appears to involve mitochondrial
dysfunction, chronic inflammation, oxidative stress, vascular compromise, and impaired cellular energy production long before significant vision loss occurs.
This emerging understanding is helping shape the next generation of nutritional support strategies, including the introduction of PreserVision AREDS3.
From Antioxidant Protection to Metabolic Support
The original AREDS and AREDS2 formulations focused heavily on antioxidants and carotenoids such as vitamins C and E, zinc, lutein, and zeaxanthin. These nutrients help protect retinal tissue from oxidative stress caused by light exposure and high metabolic activity within the retina.
While these nutrients remain critically important, researchers are now exploring whether supporting the metabolic health of retinal cells themselves may offer an additional layer of support.
The retina is one of the most energy-demanding tissues in the human body. To maintain vision, retinal cells require enormous amounts of energy generated by tiny structures inside the cell called mitochondria. Mitochondria are often referred to as the “power plants” of the cell because they convert nutrients into usable cellular energy.
As we age, mitochondrial function naturally declines. In AMD, this decline may become accelerated, contributing to inflammation, oxidative damage, impaired waste removal, and eventual retinal dysfunction.
Some researchers now believe that metabolic stress and mitochondrial dysfunction may occur before drusen become clinically visible.
Why B Vitamins Are Entering the Conversation
One of the most intriguing developments in AMD research is the growing interest in B vitamins—particularly vitamins B6, B9 (folate), and B12.
These vitamins play essential roles in:
- Cellular energy production
- Mitochondrial function
- DNA synthesis and methylation
- Nervous system health
- Regulation of homocysteine levels
Homocysteine is a naturally occurring amino acid that, when elevated, has been associated with vascular dysfunction, oxidative stress, inflammation, and impaired blood flow. Elevated homocysteine has also been linked in multiple studies to an increased risk of AMD.
This is especially important because the retina depends heavily on healthy blood flow and oxygen delivery through its delicate microvascular network.
Unlike traditional antioxidants that primarily help neutralize free radicals, B vitamins may help support the metabolic and vascular systems that sustain retinal function upstream.
AMD is increasingly being viewed not solely as a disease of oxidative damage, but also as a disorder of cellular resilience and energy metabolism.
What Makes PreserVision AREDS3 Different?
PreserVision AREDS3 builds upon the scientific legacy of AREDS2 while incorporating additional nutrients intended to support retinal metabolism and homocysteine regulation.
The formulation retains the foundational AREDS2 ingredients—vitamins C and E, zinc, copper, lutein, and zeaxanthin—while adding B vitamins that participate in important metabolic pathways involved in cellular energy production and vascular health.
This does not mean AREDS2 is obsolete. Rather, AREDS3 reflects an evolution in scientific thinking.
Instead of focusing exclusively on antioxidant defense, newer nutritional strategies seek to support multiple interconnected pathways involved in retinal aging, including oxidative stress, inflammation, mitochondrial function, vascular health, and cellular metabolism.
Importantly, this approach reflects a broader movement in medicine toward supporting biological systems earlier in the disease process, before irreversible damage occurs.
Nutrition Still Matters Most
While supplements can play an important role, they should never replace a nutrient-rich diet and healthy lifestyle.
Research consistently shows that dietary patterns such as the Mediterranean diet are associated with a lower risk of AMD progression. Foods rich in omega-3 fatty acids, leafy green vegetables, colorful fruits and vegetables, legumes, nuts, and olive oil provide nutrients and bioactive compounds that support overall retinal and systemic health.
In many ways, food remains our most powerful daily tool for promoting healthy aging.
A Note About Supplements
While nutritional supplements can be an important part of an eye health strategy, they are not appropriate for everyone. Before beginning any new supplement—including products containing B vitamins—it is important to discuss your plans with your primary care physician or healthcare team. Your age, medical history, medications, kidney function, and other health considerations may influence which supplements are right for you.
The best nutrition plan is one that is tailored to your individual needs.
Looking Ahead
The introduction of PreserVision AREDS3 reflects an exciting shift in how researchers and clinicians think about AMD.
The future of AMD management may involve not only protecting the retina from oxidative stress but also supporting the metabolic resilience of retinal cells themselves.
As our understanding of AMD biology continues to deepen, one message becomes increasingly clear: the earlier we support retinal health through evidence-based nutrition and healthy lifestyle choices, the greater opportunity we may have to influence the trajectory of disease.
For patients living with AMD—or hoping to preserve their vision for years to come—that is an encouraging direction for the future of eye care.
By: Julie A. Poteet, OD, MS, CNS, FOWNS